Journal
CURRENT RADIOPHARMACEUTICALS
Volume 2, Issue 1, Pages 49-55Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1874471010902010049
Keywords
Micro-reactor; fluorine-18; radiofluorination; [F-18]fallypride; synthesis
Funding
- Intramural Research Program of the NIH, NIMH [Z01-MH-002795]
Ask authors/readers for more resources
A commercial coiled-tube micro-reactor (NanoTek; Advion)was used as a convenient platform for the synthesis of [F-18] fallypride in small doses (0.5-1.5 mCi) for micro-PET studies of brain dopamine subtype-2 receptors in rodents. Each radiosynthesis used low amounts (20-40 mu g; 39-77 nmol) of tosylate precursor and [F-18] fluoride ion (0.5-2.5 mCi). Optimization of the labeling reaction in the apparatus, with respect to the effects of precursor amount, reaction temperature, flow rate and [F-18] fluoride ion to precursor ratio, was achieved rapidly and the decay-corrected radiochemical yield of [F-18] fallypride (up to 88%) was reproducible. The low amounts of material used in each radiosynthesis allowed crude [F-18] fallypride to be purified rapidly on an analytical-size reverse phase HPLC column, preceding formulation for intravenous injection. Scale-up of the reaction was easily achieved by continuously infusing reagent precursor solutions to obtain [F-18] fallypride in much greater quantity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available